VEGF-integrin interplay controls tumor growth and vascularization. - Wikidata - awgldk - TriplyDB

VEGF-integrin interplay controls tumor growth and vascularization.

VEGF-integrin interplay controls tumor growth and vascularization.

http://www.wikidata.org/entity/Q33821325

about

Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions Fibronectin Mechanobiology Regulates Tumorigenesis αV integrins in angiogenesis and cancer Integrin 3 Phosphorylation Dictates Its Complex with the Shc Phosphotyrosine-binding (PTB) Domain p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis Development of an acellular tumor extracellular matrix as a three-dimensional scaffold for tumor engineering Integrins in cancer: biological implications and therapeutic opportunities The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.The integrin coactivator kindlin-2 plays a critical role in angiogenesis in mice and zebrafish Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc.P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers.Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction.Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.Integrin targeting for tumor optical imaging Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin.VEGF-induced vascular permeability is mediated by FAK.Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor.Matrix-dependent perturbation of TGFβ signaling and disease Targeting integrins for the control of tumour angiogenesis.Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels Harnessing the Power of Molecular Imaging for Precision Medicine.Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions.An array of possibilities in cancer research using cytokine antibody arrays.Fibronectin conformation regulates the proangiogenic capability of tumor-associated adipogenic stromal cells Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.Synergistic control of cell adhesion by integrins and syndecans.Alpha-v integrins as therapeutic targets in oncology.Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.

P2860

Q24303934-A9C04DED-1223-439F-AA2D-531418AF480C Q24648140-17936FA0-1F60-4580-B986-2B41CCDED442 Q26738477-ECECD9EF-C5D0-43D4-A8C9-9A6BC3F6C411 Q26768515-140AFB49-58CB-4782-8C9C-2E1E7C0757BC Q26851768-1CEA395A-6820-4738-B57A-39CCF3EFCEA3 Q27664181-86DEE719-4E16-4497-A134-FE16144880D9 Q28084081-009361F2-85A5-43C2-B160-FE3906256056 Q28541338-7133842D-B984-45E9-8852-5AD7B440E0CB Q29614536-EA3D0136-7740-4958-9492-03B5009738F0 Q30441368-DC91C1EE-B561-4554-AB05-20DC81FA4ED7 Q30500398-B2118AED-BA35-4498-B5A5-8AE173DB20F6 Q30504482-94643870-7F89-4F85-AE43-274E51CFA161 Q33613299-86D6C801-74D5-44E5-BAB4-1E84E4B025A9 Q33981210-51CB1664-8F42-47D1-8620-45B93488E6BD Q33985577-216C9A57-AC37-4370-BFEB-4E147F449A5C Q34015848-6EF7B14C-1001-4E9B-9630-17BEA9F616C9 Q34102739-971B4602-9CF3-4612-8042-BC9BE3578FA7 Q34159304-0ED13185-F749-447E-B362-487194D3895B Q34391833-CBD42BF9-76FE-41A8-A67E-C6C5428C3455 Q34488846-AA653452-45EA-4FB9-980F-DC25AD10F6CB Q34606479-59558266-F7EB-4601-8271-CFF20E1B4A89 Q34912662-FE930F73-5443-4AAE-B015-5FE28E33D060 Q35024556-E324A7DA-FC13-4B28-A963-B64E7B300775 Q35238499-733EFE6B-253E-42FF-9215-7CAB7AF8E61D Q35596547-23FD56EC-2840-45DF-BBB0-4995F1AB4A1A Q35697402-F4427950-1956-48E9-AF33-7F3FD6D7B036 Q35781408-F6F1B802-F23F-4FEC-8092-CC07C7E6A92C Q35918831-EF5F6B73-CEBD-4588-8570-F0FF5C9778BA Q36184322-7F40D2DD-CE7D-473D-9006-6BD428EBF8CF Q36322066-19F18E04-78CF-43D6-A4E2-0F276193464C Q36357421-C4920CA2-0B60-4660-A8FA-0E48ED18A144 Q36535236-DFEABCD3-4770-46CF-88D2-42F71A1D2ACF Q36725218-00A72F77-6A72-4E45-8C65-28E438C30559 Q36787259-582FE85D-A1CB-4C81-96F1-13192637A412 Q36944869-852BBF1E-05C3-4C3B-950A-9787D784841D Q36952077-2C2EB2E7-2D7F-41B0-B05B-CC0808AE3486 Q36986535-86FA7E76-897C-4947-862D-CE7987131942 Q37008623-81B84AA1-2197-48E2-98AD-7A602DCE6BA0 Q37061984-769C2571-A81E-4CF1-9B8C-C46D27D0CABE Q37118164-BFFCEF21-4D79-4395-B186-D34D88BA8FB5

P2860

VEGF-integrin interplay controls tumor growth and vascularization.

http://www.wikidata.org/entity/Q33821325

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

VEGF-integrin interplay controls tumor growth and vascularization.

@ast

VEGF-integrin interplay controls tumor growth and vascularization.

@en

type

label

VEGF-integrin interplay controls tumor growth and vascularization.

@ast

VEGF-integrin interplay controls tumor growth and vascularization.

@en

prefLabel

VEGF-integrin interplay controls tumor growth and vascularization.

@ast

VEGF-integrin interplay controls tumor growth and vascularization.

@en

P1433

Q33821325-6FDF79BF-DDA1-442A-8B51-3F8C506F8D97

P1476

Q33821325-EA80510C-36BA-474E-A7CF-5F026351461B

P2093

Q33821325-28640539-046E-4790-AAEE-42F0F2F1E34E

Q33821325-287BC466-5959-4CCC-9073-C77C3E1B2F52

Q33821325-3F91EF0C-D3EF-4329-90B9-1DBF531DC036

Q33821325-A7DA0907-BC2C-40FC-BDD2-09B240698E57

Q33821325-E2D34FC6-3900-4E88-8C81-CCF11C454DC7

P2860

Q33821325-04F54F11-D7A1-4D67-B9F3-0A02DFFAF81A

Q33821325-14625317-4B0B-450A-938A-FBDDDC3F4479

Q33821325-2B03BC79-7073-4A37-B1AE-55C68713AB70

Q33821325-350E1ADE-4A01-446D-8488-A2CC7A605D61

Q33821325-3F939429-F334-4708-A047-54D161A63BC4

Q33821325-44BBFCC5-8BC9-4A48-AB87-04CA1091A82F

Q33821325-53684012-4D90-4712-BCC1-CFD9533E2D06

Q33821325-5730DE7D-63EF-4B8E-8A46-E7D457968854

Q33821325-5A193BA0-711E-4AE0-8EB0-0EA234ADAAFA

Q33821325-5A2B3AB3-A979-46CE-A64F-CFC152787AE3

P304

Q33821325-429A657B-9F81-44AA-A13F-9762690296DE

P31

Q33821325-8894B456-409C-4CB6-B81D-A8D53DA1D0BF

P356

Q33821325-C74F38F8-7F82-4A36-AD8B-908DD8510759

P407

Q33821325-369EDECE-8E7E-4CD7-8E21-B720C3693D53

P433

Q33821325-42948DCE-8C3D-4784-AC33-F836C211994D

P478

Q33821325-D98E1EE4-8FF3-4EC3-AE53-551B9F5B2056

P50

Q33821325-D0E6A7A9-E742-4B55-92D5-E8EAE16966B8

P577

Q33821325-FB100868-807C-48FC-AD29-EDFC563A79AA

P5875

Q33821325-087E3B6C-4091-4AC3-997B-647639412AA8

P698

Q33821325-238D3486-4F3A-404D-99A8-5C0B7DE1A961

P932

Q33821325-A607B188-E6B2-4F7F-BF32-1403B66E985D

P356

PNAS.0502935102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

VEGF-integrin interplay controls tumor growth and vascularization

@en

P2093

Noel Patrick McCabe

http://www.w3.org/2001/XMLSchema#string

Olga Razorenova

http://www.w3.org/2001/XMLSchema#string

Sarmishtha De

http://www.w3.org/2001/XMLSchema#string

Tatiana V Byzova

http://www.w3.org/2001/XMLSchema#string

Timothy O'Toole

http://www.w3.org/2001/XMLSchema#string

P2860

The role of alpha(v)beta(3) in prostate cancer progression

Integrin signaling

Role of angiogenesis in tumor growth and metastasis

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Vascular endothelial growth factor (VEGF) and its receptors

Vascular endothelial growth factor: basic science and clinical progress.

Molecular pathway for cancer metastasis to bone.

Role of integrins in cell invasion and migration.

Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells

Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins

P304

7589-7594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0502935102

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7844987

http://www.w3.org/2001/XMLSchema#string

P698

15897451

http://www.w3.org/2001/XMLSchema#string

P932

1129024

http://www.w3.org/2001/XMLSchema#string